How coronary physiology may help in guiding treatment of NSTEMI

Facilitators: E. Gutierrez, D. Collison

Speakers: ?. Gabaldón Badiola, S. Kjerstein Kristensen, A. Zimmerli, B. K. Andersen, O. Kim

Summary

This session explores the utility of coronary physiology in guiding NSTEMI treatment. Topics include ischemia with non-obstructive arteries, QFR quality assessment, FFR-CT impact, revascularization deferral, and sex differences in FFR-guided strategies for acute myocardial infarction with multivessel disease.

Presentations available when logged in:

Acute myocardial infarction in patients with ischaemia and non-obstructive coronary arteries
Re-analysis and quality assessment of QFR in the FAVOR III Europe trial. The REPEAT-QFR study
Impact of FFR-CT before coronary angiography on the management of nonculprit lesions among high-risk
Coronary revascularisation deferral based on QFR or FFR: A FAVOR III Europe substudy
Sex difference in FFR guided strategy in AMI with multivessel disease

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

How coronary physiology may help in guiding treatment of NSTEMI

Log in or create account for free